Literature DB >> 3949107

Salicylates for the sulfa-sensitive patient with ulcerative colitis?

C J Hawkey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3949107     DOI： 10.1016/0016-5085(86)90890-5

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  3 in total

Review 1.  Immunosuppressive drugs in inflammatory bowel disease. A review of their mechanisms of efficacy and place in therapy.

Authors:  A B Hawthorne; C J Hawkey
Journal:  Drugs       Date:  1989-08       Impact factor: 9.546

Review 2.  Medical treatment of inflammatory bowel disease: new therapies, new drugs.

Authors:  L R Sutherland
Journal:  CMAJ       Date:  1987-11-01       Impact factor: 8.262

3.  Olsalazine versus placebo in the treatment of mild to moderate ulcerative colitis: a randomised double blind trial.

Authors:  G E Feurle; D Theuer; S Velasco; B A Barry; D Wördehoff; A Sommer; G Jantschek; W Kruis
Journal:  Gut       Date:  1989-10       Impact factor: 23.059
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.